Figure S2. PET-CT images of the patients. This figure shows PET-CT results of the patient (pre-treatment, after 2 cycles of chemotherapy and after 8 cycles of chemotherapy). A: Pre-treatment PET-CT showed multiple lesions in subcutaneous tissue, muscle et al. B: PET-CT after 2 cycles of SMILE regimen, DS = 5. C: PET-CT after 8 cycles of modified SMILE regimen, complete remission. (TIFF 5450 kb
Figure S3. NBL tumor of Patient #3 showed area with pathological response to chemotherapy. HE and IH...
PET images of C6 and HeLa tumor-bearing mice between 30 and 60 min after injection of 50 MBq of [11C...
Table S1. Ranking of patients for SUVmean, TLG, and MATV according to the four VOI delineation techn...
Figure S1. IgH, IgK and TCR rearrangement. This figure shows results of IgH, IgK and TCR rearrangeme...
Table S1. Summary of pediatric EBV + PTCL cases. This table shows the clinical features and outcomes...
STAT5B variant investigation by Sanger Sequencing. This file provides the method of STAT5B variant i...
Table S2. The clinicopathological difference in ENKTL, STLC and our case. This table shows 2 main ki...
Additional examples of focal tumour uptake of 89Zr-RG7356 at 96Â h p.i.. From left to right: low dos...
Table S1. Genomic analysis of pre-treatment tumor in complete responder with DLBCL. Table S2. Periph...
Figure S1. Relative percentage of FoxP3+CD4+T cells before and after treatment.. (PNG 43 kb
Supplemental materials. Results of additional analysis on delineation with a fixed relative threshol...
Figure S1. Squished plot of K111 PacBio sequences from patients with CTCL. The squished maps show se...
Table S1. Clinical Features of Cutaneous T-cell Lymphoma patients: age, gender, mortality, diagnosis...
Figure S1. PET imaging with apoptotic radiotracers. Representative PET images with (A) 18F-ICMT-11 a...
Figure S3. A: Comparison of in vivo FDG uptake in the spleen with and without partial volume correct...
Figure S3. NBL tumor of Patient #3 showed area with pathological response to chemotherapy. HE and IH...
PET images of C6 and HeLa tumor-bearing mice between 30 and 60 min after injection of 50 MBq of [11C...
Table S1. Ranking of patients for SUVmean, TLG, and MATV according to the four VOI delineation techn...
Figure S1. IgH, IgK and TCR rearrangement. This figure shows results of IgH, IgK and TCR rearrangeme...
Table S1. Summary of pediatric EBV + PTCL cases. This table shows the clinical features and outcomes...
STAT5B variant investigation by Sanger Sequencing. This file provides the method of STAT5B variant i...
Table S2. The clinicopathological difference in ENKTL, STLC and our case. This table shows 2 main ki...
Additional examples of focal tumour uptake of 89Zr-RG7356 at 96Â h p.i.. From left to right: low dos...
Table S1. Genomic analysis of pre-treatment tumor in complete responder with DLBCL. Table S2. Periph...
Figure S1. Relative percentage of FoxP3+CD4+T cells before and after treatment.. (PNG 43 kb
Supplemental materials. Results of additional analysis on delineation with a fixed relative threshol...
Figure S1. Squished plot of K111 PacBio sequences from patients with CTCL. The squished maps show se...
Table S1. Clinical Features of Cutaneous T-cell Lymphoma patients: age, gender, mortality, diagnosis...
Figure S1. PET imaging with apoptotic radiotracers. Representative PET images with (A) 18F-ICMT-11 a...
Figure S3. A: Comparison of in vivo FDG uptake in the spleen with and without partial volume correct...
Figure S3. NBL tumor of Patient #3 showed area with pathological response to chemotherapy. HE and IH...
PET images of C6 and HeLa tumor-bearing mice between 30 and 60 min after injection of 50 MBq of [11C...
Table S1. Ranking of patients for SUVmean, TLG, and MATV according to the four VOI delineation techn...